Cannabis with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD)
Cannabis with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) - inhaled and vaporised cannabis flower
Loading study record…
The acute effects of cannabis may differ between adolescents and adults. Furthermore, these effects may be tempered by the presence of cannabidiol. This double-blind, placebo-controlled, crossover experiment investigates the acute effects of cannabis (with and without cannabidiol) on subjective effects, behavioural responses and neural functioning in 16-17 year-olds and 26-29 year-olds who regularly use cannabis (0.5-3 days per week).
Locally preserved from ClinicalTrials.govOpen ClinicalTrials.govlast source update 2021-09-29
What this record can show
This locally preserved record separates the registered protocol from source-reported registry results. Neither is a treatment recommendation.
Registry facts
Linked local records
Local links use governed condition terms or exact source-reported intervention names. They are navigation candidates, not efficacy claims.
Research network
Interventions
Cannabis with delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) - inhaled and vaporised cannabis flower
Cannabis with THC without CBD - inhaled and vaporised cannabis flower
Placebo cannabis, without THC and without CBD - inhaled and vaporised
Eligibility
primary outcomes
Time frame: Measured once, 2 hours after the start of drug administration, on each drug condition
Measured by total Psychotomimetic States Inventory (PSI) score
Time frame: Measured once, 2 hours after the start of drug administration, on each drug condition
Measured by delayed prose recall performance
Time frame: Measured 20 minutes after the start of drug administration, on each drug condition
Measured by self-reported 'feel drug effect', rated from 0 (not at all) to 10 (extremely)
secondary outcomes
Time frame: Measured -30 minutes, 20 minutes, 30 minutes, 2 hours, and 2 hours & 40 minutes after the start of drug administration, on each drug condition
Feel drug effect, like drug effect, dislike drug effect, alert, want to have cannabis, happy, relaxed, anxious, paranoid, mentally impaired, stoned, dry mouth, unmotivated, intensified sensory perception, want to listen to music, want food, want to see friends, rated from 0 (not at all) to 10 (extremely)
Time frame: Measured between 40 minutes and 1 hour & 20 minutes after the start of drug administration, on each drug condition
Reward anticipation and reward feedback, response inhibition, spatial working memory, and resting-state
Time frame: Measured 1 hour & 30 minutes after the start of drug administration, on each drug condition
Measuring glutamate levels in the dorsal striatum
Time frame: Measured 2 hours & 40 minutes after the start of drug administration, on each drug condition
Kay et al. (1987). Higher scores reflect stronger positive and negative symptoms.
Time frame: Measured 2 hours & 20 minutes after the start of drug administration, on each drug condition
Measured by the physical effort task ('apple-gathering' task) as described in Husain \& Roiser (2018)
Time frame: Measured 2 hours & 30 minutes after the start of drug administration, on each drug condition
Measured by subjective liking in response to chocolate, music and cartoons, rated from 0 (not at all) to 10 (extremely), similar to Lawn et al. (2015)
Time frame: Measured 2 hours & 10 minutes after the start of drug administration, on each drug condition
Measured by the visual dot-probe task, as described in Morgan et al. (2010)
Time frame: Measured -30 minutes, 20 minutes, 30 minutes, 2 hours, and 2 hours & 40 minutes after the start of drug administration, on each drug condition
Publications
Measuring heart rate
Time frame: Measured -30 minutes, 20 minutes, 30 minutes, 2 hours, and 2 hours & 40 minutes after the start of drug administration, on each drug condition
Measuring systolic and diastolic blood pressure.
Time frame: Measured -30 minutes, 20 minutes, 30 minutes, and 2 hours & 40 minutes after the start of drug administration, on each drug condition
Measuring THC and CBD and metabolites; and endocannabinoids
Time frame: Measured 2 hours & 40 minutes after the start of drug administration, on each drug condition
Bremner et al. (1998). Higher scores reflect greater dissociation.